Clinical Trials Directory

Trials / Terminated

TerminatedNCT02887196

Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment

Status
Terminated
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Twenty-five women will be followed through their breast cancer treatment. The women will be asked to provide their opinions and desires for lifestyle intervention at different times throughout treatment. In addition, basic clinical data will be collected . The primary goal of this pilot study is to investigate the physical and behavioral changes that occur in patients receiving treatment for breast cancer.

Detailed description

In this cross sectional, longitudinal, observational study, 25 women will be followed through their treatment for stage I-III breast cancer. The women will be asked to provide their opinions and desires for lifestyle intervention at four timepoints throughout treatment. In addition to qualitative data, basic clinical data will be collected (anthropometrics, vital signs, dietary intake, and physical activity). The primary goal of this pilot study is to investigate the anthropometric and behavioral changes that occur in patients undergoing adjuvant chemotherapy for breast cancer. Aim 1: To better understand patients' attitudes toward and perceived barriers to nutrition and physical activity interventions during neoplastic treatment. Hypothesis: Patients' reported attitudes, motivation, and perceived barriers will change throughout treatment. Aim 2: To measure the physical and metabolic changes that occur throughout neoplastic treatment for breast cancer. Hypothesis: Over 50% of the participants will gain body weight during treatment and metabolic parameters will trend with body weight change.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2018-09-11
Completion
2018-09-18
First posted
2016-09-02
Last updated
2021-07-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02887196. Inclusion in this directory is not an endorsement.